Advertisement

Role of the Human Immunodeficiency Virus Type I Envelope Glycoprotein in Cytopathic Effect

  • Joseph Sodroski
  • William Haseltine
  • Mark Kowalski
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 300)

Abstract

The pathogenesis of acquired immune deficiency syndrome (AIDS) is characterized by a depletion of CD4-positive lymphocytes (for review, see Fauci, 1988). HIV-1 infection of CD4-positive lymphocytes and, to a lesser extent, monocyte/macrophages in tissue culture is accompanied by cytopathic effects (Popovic et al., 1984). The cytopathic effects follow a temporal course with the initial phase consisting of a period of formation of multinucleated giant cells or syncytia. This is followed by a phase of single cell lysis, which in turn is followed by a period of host cell resistance to cytopathic effect. In the latter phase, cells often continue to produce high titers of viruses that are cytopathic for fresh target cells, without undergoing obvious cytopathic effects.

Keywords

Human Immunodeficiency Virus Type Acquire Immune Deficiency Syndrome Cytopathic Effect Envelope Glycoprotein Syncytium Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J. Allen, T.H. Lee, M.F. McLane, J.G. Sodroski, W.A. Haseltine, and M. Essex, Identification of the major envelope glycoprotein product of HTLV-III, Science 228:1091 (1985).CrossRefGoogle Scholar
  2. A.I. Dayton, J.G. Sodroski, C.A. Rosen, W.C. Goh, and W.A. Haseltine, The trans-activator gene of the human T-cell lymphocyte virus type III is required for replication, Cell 44:941 (1986).PubMedCrossRefGoogle Scholar
  3. A. DeRossi, G. Franchini, A. Aldovini, A. DelMistro, L. Chieco-Bianchi, R.C. Gallo, and F. Wong-Staal, Differential response to the cytopathic effects of HTLV-III superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I, Proc. Natn. Acad. Sci. U.S.A. 83:4297 (1986).CrossRefGoogle Scholar
  4. A. Fauci, The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis, in: “AIDS 1988,” Ruth Kulstad, ed., American Association for the Advancement of Science, Washington, D.C. (1988).Google Scholar
  5. A. Fisher, L. Ratner, M. Mitsuya, L. Marselle, M.E. Harper, S. Broder, R.C. Gallo and F. Wong-Staal, Infectious mutants of HTLV-III with changes in the 3′ region and markedly reduced cytopathic effects, Science 233:655 (1986).PubMedCrossRefGoogle Scholar
  6. M. Kowalski, J. Potz, L. Basiripour, T. Dorfman, W.C. Goh, E. Terwilliger, A. Dayton, C. Rosen, W.A. Haseltine, and J.G. Sodroski, Functional regions of the human immunodeficiency virus envelope glycoprotein, Science 237:1351 (1987).PubMedCrossRefGoogle Scholar
  7. J. Lifson, M. Feinberg, G. Reyes, L. Rabin, B. Banapour, S. Chakrabarti, B. Moss, F. Wong-Staal, K. Steimer, and E. Engleman, Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein, Nature 323:725 (1986).PubMedCrossRefGoogle Scholar
  8. M. Popovic, M.G. Sarngadharan, E. Read, and R. C. Gallo, Detection, isolation, and continous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS, Science 224:497 (1984).PubMedCrossRefGoogle Scholar
  9. W.G. Robey, B. Safai, S. Oroszlan, L. Arthur, M. Gonda, R.C. Gallo and P. Fischinger, Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients, Science 228:pp593 (1985).Google Scholar
  10. J. Sodroski, W.C. Goh, C.A. Rosen, A. Tartar, D. Porteteile, A. Burny, and W.A. Haseltine, Replicative and cytopathic potential of human T-lymphotropic virus type III with sor gene deletions, Science 240:1549 (1986).CrossRefGoogle Scholar
  11. J. Sodroski, W.C. Goh, C.A. Rosen, K. Campbell, and W.A. Haseltine, Role of the HTLV-III envelope in syncytium formation and cytopathicity, Nature 322:470 (1986).PubMedCrossRefGoogle Scholar
  12. J. Sodroski and W.A. Haseltine, The Molecular Biology of HIV Replication and Pathogenesis, in: “AIDS 1988”, Ruth Kulstad, ed., American Association for the Advancement of Science, Washington, D.C. (1988).Google Scholar
  13. E. Terwilliger, J.G. Sodroski, C.A. Rosen, and W.A. Haseltine, Effects of mutations within the 3′-ORF region of the HTLV-III/LAV on replication and cytopathicity, J. Virol. 60:754 (1986).PubMedGoogle Scholar
  14. F.D. Veronese, A.L. DeVico, T. Copeland, S. Oroszlan, R.C. Gallo and M.G. Sarngadharan, Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene, Science 229:1402 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Joseph Sodroski
    • 1
  • William Haseltine
    • 1
    • 2
  • Mark Kowalski
    • 1
  1. 1.Laboratory of Human Retrovirology, Department of PathologyHarvard Medical School, Dana-Farber Cancer InstituteBostonUSA
  2. 2.Department of Cancer BiologyHarvard School of Public HealthBostonUSA

Personalised recommendations